SOR-C13 shows promise in different cancers

SOR-C13 shows promise in different cancers

Cancer-News

9 months
177 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 potentially shows promise in ovarian,
metastatic prostate and pancreatic cancer.
Up Next Autoplay